Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Oct. 28, 2012		Oct. 30, 2011
OPERATING ACTIVITIES
Net income	$ 346,225		$ 236,635
Adjustments to reconcile to net cash provided by operating activities:
Depreciation and amortization	102,544		98,768
Equity in income of unconsolidated affiliates	(5,043)		(856)
Deferred taxes	26,499		16,657
Stock-based compensation expense	26,372		31,118
Impairment of long-lived assets	259		2,213
Debt modification costs	0		16,233
Expense recorded for settlement of unfavorable contract	0		20,709
Changes in operating assets and liabilities:
Trade receivables, net	(122,277)		(172,182)
Inventories, net	(50,622)		(126,173)
Accounts payable, accrued expenses and deferred revenue	(38,849)		(11,641)
Prepaid expenses	30,011		10,606
Other, net	(29,741)		51,253
Net cash provided by operating activities	285,378		173,340
INVESTING ACTIVITIES(1)
Business acquisitions, net of cash acquired	(13,104)		(25,000)
Purchase of property, plant and equipment	(137,048)		(117,892)
Contingent purchase price payments	(35,694)		(35,196)
Investments in unconsolidated affiliates	(1,900)		(48,700)
Net cash used by investing activities	(187,746)	[1]	(226,788)	[1]
FINANCING ACTIVITIES(1)
Net proceeds from revolving credit facilities	130,000		0
Net (payments on) proceeds from short-term borrowings	(526)		7,952
Repayment of credit facilities	(167,414)		(286,243)
Payment of debt modification costs	0		(10,634)
Proceeds from settlement of awards under stock plans	7,121		12,264
Excess tax benefits from awards under stock plans	8,327		4,560
Cash dividends	(8,237)		(8,153)
Acquisition of treasury shares	(13,955)		(5,257)
Payments of capital lease obligations	(8,565)		(7,660)
Net cash used by financing activities	(53,249)	[1]	(293,171)	[1]
Effect of exchange rate changes on cash and cash equivalents	(950)		7,882
Increase (decrease) in cash and cash equivalents	43,433		(338,737)
Cash and cash equivalents at beginning of period	233,197		498,718
Cash and cash equivalents at end of period	$ 276,630		$ 159,981

[1] See Note 15 for information on noncash investing and financing transactions.